CI
AMGN icon

Corient IA’s Amgen AMGN Stock Holding History

Corient IA’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Sell
890
-110
-11% -$39.2K 0.29% 132
2025
Q4 		$327K Hold
1,000
– – 0.31% 136
2025
Q3 		$282K Hold
1,000
– – 0.21% 189
2025
Q2 		$279K Hold
1,000
– – 0.16% 233
2025
Q1 		$312K Buy
+1,000
New +$295K 0.22% 196

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Corient IA's AMGN Position: Q1 2026 in Review

Corient IA reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $39.2K and leaving 890 shares worth $313K. The position accounts for 0.29% of the portfolio, ranked #132.

Corient IA first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. The position peaked at $327K in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Corient IA held 890 shares of Amgen worth $313K as of Q1 2026.
  • Corient IA sold 110 Amgen shares in Q1 2026, an estimated $39.2K.
  • Amgen made up 0.29% of Corient IA's portfolio in Q1 2026, its #132 holding.
  • Corient IA first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Amgen position peaked at $327K in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.